Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 2 Aug 21 424B4 Prospectus supplement with pricing info
- 30 Jul 21 EFFECT Notice of effectiveness
-
26 Jul 21 S-1/A IPO registration (amended)
- 9 Jul 21 S-1 IPO registration
OMGA similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement No. 333-257794 on Form S-1 of our report dated May 7, 2021 (July 26, 2021, as to the effects of the reverse stock split as described in Note 17) relating to the financial statements of Omega Therapeutics, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
July 26, 2021